|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current assets | |||||||||
| Cash and cash equivalents | |||||||||
| Accounts receivable and other current assets (Note 6) | |||||||||
| Prepaid expenses | |||||||||
| Inventories (Note 7) | |||||||||
| Regulatory assets (Note 8) | |||||||||
| Total current assets | |||||||||
| Other assets (Note 9) | |||||||||
| Regulatory assets (Note 8) | |||||||||
| Property, plant and equipment, net (Note 10) | |||||||||
| Intangible assets, net (Note 11) | |||||||||
| Goodwill (Note 12) | |||||||||
| Total assets | |||||||||
| LIABILITIES AND EQUITY | |||||||||
| Current liabilities | |||||||||
| Short-term borrowings (Note 14) | |||||||||
| Accounts payable and other current liabilities (Note 13) | |||||||||
| Regulatory liabilities (Note 8) | |||||||||
| Current installments of long-term debt (Note 14) | |||||||||
| Current installments of finance leases (Note 16) | |||||||||
| Total current liabilities | |||||||||
| Regulatory liabilities (Note 8) | |||||||||
| Deferred income taxes (Note 23) | |||||||||
| Long-term debt (Note 14) | |||||||||
| Finance leases (Note 15) | |||||||||
| Other liabilities (Note 16) | |||||||||
| Total liabilities | |||||||||
| Equity | |||||||||
| Common shares | |||||||||
| Preference shares (Note 18) | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated other comprehensive income (Note 19) | |||||||||
| Retained earnings | |||||||||
| Shareholders' equity | |||||||||
| Non-controlling interests | |||||||||
| Total equity | |||||||||
| Total liabilities and equity | |||||||||
Loading...
